Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma

Low-grade gliomas account for 20% of all gliomas and typically occur in young patients who survive years with their illness [1 –3]. Choice of treatment must therefore weigh the goals of disease control against late adverse effects [4]. Radiation therapy has been shown to increase PFS in LGG [5], but with risk of late neurocognitive and neuroendocrine toxicity [6–8].

Source: Radiotherapy and Oncology - May 9, 2019 Category: Radiology Authors: Shervin Tabrizi, Beow Y. Yeap, Janet C. Sherman, Lisa B. Nachtigall, Mary K. Colvin, Michael Dworkin, Barbara C. Fullerton, Juliane Daartz, Trevor J. Royce, Kevin S. Oh, Tracy T. Batchelor, William T. Curry, Jay S. Loeffler, Helen A. Shih Tags: Original Article Source Type: research